Position in ENTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,774,581
+$3,426,521 QoQ
Shares Held
464,649
+75.3% QoQ
Ownership
1.60%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ENTA ranks #178 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ENTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,774,581 | 464,649 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,348,060 | 265,088 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,450,728 | 218,816 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,992,202 | 166,433 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $877,979 | 116,135 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $719,862 | 130,410 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $712,200 | 123,861 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,658,977 | 160,133 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,099,997 | 84,811 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,583,446 | 90,690 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,756,291 | 186,641 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,260,823 | 291,927 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $5,116,076 | 239,069 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $9,304,839 | 230,090 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $10,952,947 | 235,446 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $9,056,242 | 174,595 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $6,540,087 | 138,356 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $7,153,660 | 100,501 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,947,501 | 119,651 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,813,479 | 102,332 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $6,312,397 | 143,431 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,704,017 | 135,929 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,795,529 | 161,414 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,424,471 | 336,926 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,263,786 | 363,748 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $19,019,893 | 369,821 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||